Hideaki Bujo Selected Research

Hideaki Bujo Research Topics

Disease

15	Atherosclerosis 12/2016 - 04/2002
14	Coronary Artery Disease (Coronary Atherosclerosis) 08/2022 - 04/2002
13	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2022 - 02/2002
10	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 07/2021 - 02/2011
9	Alzheimer Disease (Alzheimer's Disease) 02/2019 - 08/2004
7	Xanthomatosis (Xanthoma) 06/2022 - 01/2012
7	Hypercholesterolemia 09/2018 - 01/2003
7	Insulin Resistance 09/2010 - 09/2004
6	Hypertriglyceridemia 09/2022 - 01/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 01/2012
5	Inborn Genetic Diseases (Disease, Hereditary) 05/2022 - 01/2004
5	Type 2 Diabetes Mellitus (MODY) 11/2016 - 09/2004
4	Dyslipidemias (Dyslipidemia) 02/2021 - 01/2004
4	Atherosclerotic Plaque (Atheroma) 05/2020 - 06/2006
4	Weight Loss (Weight Reduction) 01/2018 - 09/2004
4	Hypoxia (Hypoxemia) 01/2016 - 04/2008
3	Hypertension (High Blood Pressure) 05/2022 - 01/2004
3	Corneal Opacity 07/2021 - 10/2011
3	Proteinuria 07/2021 - 10/2011
3	Coronary Disease (Coronary Heart Disease) 02/2021 - 02/2002
3	Neoplasms (Cancer) 12/2016 - 01/2015
3	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2014 - 04/2008
3	Body Weight (Weight, Body) 01/2013 - 12/2008
3	Cognitive Dysfunction 01/2013 - 01/2012
3	Obesity 02/2009 - 05/2007
2	Carotid Artery Diseases 06/2022 - 02/2002
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 03/2016
2	Anemia 07/2021 - 05/2013
2	Renal Insufficiency (Renal Failure) 07/2021 - 08/2014
2	Epiretinal Membrane (Epiretinal Membranes) 05/2017 - 08/2014
2	Retinal Perforations 05/2017 - 08/2014
2	Frontotemporal Dementia (Semantic Dementia) 01/2015 - 01/2012
2	Stable Angina 11/2014 - 01/2013
2	Hyperplasia 04/2014 - 01/2005
2	Leukemia 04/2014 - 10/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2014 - 10/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2008 - 06/2008
2	Glucose Intolerance 05/2007 - 09/2004
2	Diabetes Mellitus 05/2007 - 01/2004
1	Pancreatitis 09/2022
1	Bacterial Infections (Bacterial Infection) 10/2021
1	Sepsis (Septicemia) 10/2021
1	Sitosterolemia 05/2020
1	Pre-Eclampsia (Preeclampsia) 10/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Rhinosinusitis 10/2017
1	Vascular Calcification 10/2017

Drug/Important Bio-Agent (IBA)

16	oxidized low density lipoproteinIBA 06/2022 - 02/2002
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2012
13	LipidsIBA 08/2022 - 01/2004
12	Lipoproteins (Lipoprotein)IBA 08/2022 - 02/2002
12	LDL Receptors (LDL Receptor)IBA 05/2020 - 01/2004
11	LDL CholesterolIBA 06/2022 - 02/2002
11	HDL CholesterolIBA 05/2022 - 04/2002
9	Triglycerides (Triacylglycerol)IBA 09/2022 - 04/2002
8	LDL Lipoproteins (beta Lipoproteins)IBA 06/2022 - 01/2004
8	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2007
6	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 09/2018 - 02/2011
6	LigandsIBA 01/2018 - 03/2014
5	EnzymesIBA 10/2021 - 02/2011
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020 - 10/2006
5	Amyloid (Amyloid Fibrils)IBA 02/2019 - 02/2007
4	Probucol (Lorelco)FDA Link 06/2022 - 12/2008
3	HDL LipoproteinsIBA 02/2021 - 01/2012
3	CholesterolIBA 01/2020 - 01/2004
3	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 09/2004
3	Malondialdehyde (Propanedial)IBA 10/2015 - 04/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 11/2006
2	ApolipoproteinsIBA 08/2022 - 08/2004
2	AntioxidantsIBA 02/2021 - 12/2008
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2019 - 01/2018
2	Immunoglobulin G (IgG)IBA 10/2017 - 11/2016
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2017 - 01/2012
2	AntibodiesIBA 11/2016 - 10/2016
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 12/2015 - 08/2004
2	Amino Acids FDA Link 01/2015 - 01/2003
2	Retinaldehyde (Retinal)IBA 06/2014 - 04/2008
2	Urokinase Plasminogen Activator ReceptorsIBA 03/2014 - 04/2013
2	Messenger RNA (mRNA)IBA 04/2013 - 04/2008
2	Advanced Glycation End ProductsIBA 09/2010 - 05/2007
2	Insulin (Novolin)FDA Link 09/2010 - 09/2004
2	CytokinesIBA 04/2007 - 03/2007
2	low density lipoprotein inhibitorIBA 01/2004 - 04/2002
1	Apolipoproteins E (ApoE)IBA 09/2022
1	Lipoprotein(a)IBA 08/2022
1	Apolipoproteins B (ApoB)IBA 07/2021
1	campesterolIBA 05/2020
1	gamma-sitosterol (beta-sitosterol)IBA 05/2020
1	SterolsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	Apolipoprotein E4IBA 02/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Neuregulin-1 (Neuregulin 1)IBA 01/2018
1	histidine-rich proteinsIBA 01/2018

Therapy/Procedure

9	Therapeutics 07/2021 - 02/2009
3	Percutaneous Coronary Intervention 05/2020 - 01/2013
2	Secondary Prevention 02/2021 - 06/2016
1	Renal Dialysis (Hemodialysis) 07/2021